FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019506220> ?p ?o ?g. }

• W2019506220 endingPage "535" @default.
• W2019506220 startingPage "525" @default.
• W2019506220 abstract "Recombinant immunoglobulin libraries of single chain molecules (sc) from the variable domains of antibody light and heavy chains (Fv), have great promise for new approaches to radioimmunotherapy (RIT). However, creating and evaluating scFv from diverse sources is time consuming and differences in molecular format can influence in vitro and in vivo characteristics. Furthermore, scFv do not have optimal characteristics for targeting therapy to tumor because of their small size and univalent binding. Diabody molecules at least twice the size of scFv are better for RIT because bivalent and bispecific molecules can be constructed. A polymerase chain reaction (PCR) based primer system was created to easily convert scFv genes into a diabody gene format, once they have been placed into pCANTAB 5E, a readily available vector. The primer system for this diabody gene platform was developed and tested by constructing an anti-lymphoma/anti-chelate, bispecific diabody (anti-HLA-DR/anti-DOTA). Two mouse scFv libraries were screened for reactive clones using recombinant phage display techniques. Selected mouse anti-HLA-DR and anti-DOTA scFv genes were combined, ligated into the pCANTAB 5E vector that co-expressed these self-assembling scFv in E. coli as two mismatched nonlinked pairs (VHA-link-VLB; VHB-link-VLA). The diabody protein that was purified from periplasm had the expected molecular characteristics when analyzed by sequencing, chromatography, electrophoresis and Western blot. This modular gene design platform provides methodology for easy and rapid creation of diabody molecules from diverse scFv libraries. Diabodies from various scFv can easily be produced, thereby facilitating comparative preclinical studies en route to development of new tumor targeting molecules." @default.
• W2019506220 created "2016-06-24" @default.
• W2019506220 creator A5003879927 @default.
• W2019506220 creator A5033215159 @default.
• W2019506220 creator A5038808449 @default.
• W2019506220 creator A5044505402 @default.
• W2019506220 creator A5066901504 @default.
• W2019506220 date "2001-12-01" @default.
• W2019506220 modified "2023-10-16" @default.
• W2019506220 title "Anti-HLA-DR/anti-DOTA Diabody Construction in a Modular Gene Design Platform: Bispecific Antibodies for Pretargeted Radioimmunotherapy" @default.
• W2019506220 cites W1224513713 @default.
• W2019506220 cites W127928206 @default.
• W2019506220 cites W1492813788 @default.
• W2019506220 cites W1502834515 @default.
• W2019506220 cites W1555021163 @default.
• W2019506220 cites W1869307723 @default.
• W2019506220 cites W1892026381 @default.
• W2019506220 cites W1978264451 @default.
• W2019506220 cites W1982501635 @default.
• W2019506220 cites W1982987387 @default.
• W2019506220 cites W1985031636 @default.
• W2019506220 cites W2001885738 @default.
• W2019506220 cites W2006174330 @default.
• W2019506220 cites W2007252162 @default.
• W2019506220 cites W2011261569 @default.
• W2019506220 cites W2013285346 @default.
• W2019506220 cites W2016103121 @default.
• W2019506220 cites W2021007834 @default.
• W2019506220 cites W2023760011 @default.
• W2019506220 cites W2025827008 @default.
• W2019506220 cites W2026305248 @default.
• W2019506220 cites W2036358607 @default.
• W2019506220 cites W2052332203 @default.
• W2019506220 cites W2053344913 @default.
• W2019506220 cites W2054357328 @default.
• W2019506220 cites W2057143946 @default.
• W2019506220 cites W2057995332 @default.
• W2019506220 cites W2059321902 @default.
• W2019506220 cites W2067073802 @default.
• W2019506220 cites W2073517578 @default.
• W2019506220 cites W2074598941 @default.
• W2019506220 cites W2089652099 @default.
• W2019506220 cites W2106186085 @default.
• W2019506220 cites W2128997140 @default.
• W2019506220 cites W2156037313 @default.
• W2019506220 cites W2157736308 @default.
• W2019506220 cites W2175687390 @default.
• W2019506220 cites W2267583049 @default.
• W2019506220 doi "https://doi.org/10.1089/10849780152752128" @default.
• W2019506220 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11789029" @default.
• W2019506220 hasPublicationYear "2001" @default.
• W2019506220 type Work @default.
• W2019506220 sameAs 2019506220 @default.
• W2019506220 citedByCount "28" @default.
• W2019506220 countsByYear W20195062202012 @default.
• W2019506220 countsByYear W20195062202013 @default.
• W2019506220 countsByYear W20195062202014 @default.
• W2019506220 countsByYear W20195062202016 @default.
• W2019506220 countsByYear W20195062202017 @default.
• W2019506220 countsByYear W20195062202022 @default.
• W2019506220 crossrefType "journal-article" @default.
• W2019506220 hasAuthorship W2019506220A5003879927 @default.
• W2019506220 hasAuthorship W2019506220A5033215159 @default.
• W2019506220 hasAuthorship W2019506220A5038808449 @default.
• W2019506220 hasAuthorship W2019506220A5044505402 @default.
• W2019506220 hasAuthorship W2019506220A5066901504 @default.
• W2019506220 hasConcept C104317684 @default.
• W2019506220 hasConcept C153911025 @default.
• W2019506220 hasConcept C159654299 @default.
• W2019506220 hasConcept C178790620 @default.
• W2019506220 hasConcept C185592680 @default.
• W2019506220 hasConcept C186268636 @default.
• W2019506220 hasConcept C197404232 @default.
• W2019506220 hasConcept C200201100 @default.
• W2019506220 hasConcept C2779281246 @default.
• W2019506220 hasConcept C2779931791 @default.
• W2019506220 hasConcept C36394416 @default.
• W2019506220 hasConcept C40767141 @default.
• W2019506220 hasConcept C54355233 @default.
• W2019506220 hasConcept C55493867 @default.
• W2019506220 hasConcept C86803240 @default.
• W2019506220 hasConceptScore W2019506220C104317684 @default.
• W2019506220 hasConceptScore W2019506220C153911025 @default.
• W2019506220 hasConceptScore W2019506220C159654299 @default.
• W2019506220 hasConceptScore W2019506220C178790620 @default.
• W2019506220 hasConceptScore W2019506220C185592680 @default.
• W2019506220 hasConceptScore W2019506220C186268636 @default.
• W2019506220 hasConceptScore W2019506220C197404232 @default.
• W2019506220 hasConceptScore W2019506220C200201100 @default.
• W2019506220 hasConceptScore W2019506220C2779281246 @default.
• W2019506220 hasConceptScore W2019506220C2779931791 @default.
• W2019506220 hasConceptScore W2019506220C36394416 @default.
• W2019506220 hasConceptScore W2019506220C40767141 @default.
• W2019506220 hasConceptScore W2019506220C54355233 @default.
• W2019506220 hasConceptScore W2019506220C55493867 @default.
• W2019506220 hasConceptScore W2019506220C86803240 @default.
• W2019506220 hasIssue "6" @default.
• W2019506220 hasLocation W20195062201 @default.

• next